DOTA-NHS-ester hexafluorophosphate TFA
Based on 2 publication(s) in Google Scholar
DOTA-NHS-ester hexafluorophosphate TFA is a bifunctional reagent containing a DOTA chelating group and an NHS ester. DOTA-NHS-ester hexafluorophosphate TFA can be conjugated to proteins/antibodies/HSA via primary amino groups for radiolabeling with radiometals, and when combined with 16-amino-1-hexadecanethiol hydrochloride, it enables the construction of self-assembled monolayers on gold surfaces for lectin microarrays. DOTA-NHS-ester hexafluorophosphate TFA can be used to prepare DOTA-HSA-Z (HER2:342) imaging probes, as well as to construct Trop2-targeted radiotherapeutic and diagnostic probes for pancreatic cancer.
For research use only. We do not sell to patients.
- CAS No.: 1823122-52-6
- Formula: C20H31N5O10.C2HF3O2.F6P.H
- Molecular Weight:761.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) DOTA-NHS-ester hexafluorophosphate TFA
More-
In Vivo Efficacy Study
-
In Vivo Efficacy Study
Biological Activity
Description
In Vitro
DOTA-NHS-ester (10 mM; overnight) hexafluorophosphate TFA in combination with 16-amino-1-hexadecanethiol hydrochloride successfully modifies gold chip surfaces, producing a rough surface topography and characteristic infrared absorption peaks consistent with covalent coupling of the reagent[2].
DOTA-NHS-ester (5-20 mM; 2 h) hexafluorophosphate TFA modification concentration on gold biochips positively correlates with IgG protein binding capacity, with 10 mM selected as the optimal working concentration balancing performance and reagent efficiency[2].
DOTA-NHS-ester (10 mM; overnight) hexafluorophosphate TFA modification of gold biochips proceeds effectively at both 25 °C and 37 °C, with 25 °C selected as the optimal working temperature for practical convenience[2].
DOTA-NHS-ester (10 mM; overnight) hexafluorophosphate TFA modified gold biochips support specific, concentration-dependent binding of ConA lectin and its corresponding antibody, validating the platform's suitability for lectin-based assays[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1823122-52-6
-
Molecular Weight 761.48
-
Formula C20H31N5O10.C2HF3O2.F6P.H
-
SMILES
O=C(CN1CCN(CCN(CCN(CC1)CC(O)=O)CC(ON2C(CCC2=O)=O)=O)CC(O)=O)O.O=C(C(F)(F)F)O.[F-][P+5]([F-])([F-])([F-])([F-])[F-].[H+]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
-
DOTA-NHS-ester hexafluorophosphate TFA purchased from MedChemExpress. Usage Cited in: Adv Nanobiomed Res. 2023 Sep 3.
PSP–NH2 was incubated with DOTA–NHS–ester for 1 h and conjugated with mPEG–NHS. Then, the particles were mixed with 64Cu (OAc)2 at 50 ℃ for 1 h to obtain the 64Cu-labelled PSP. PSP@Ab@PEG exhibited increased blood circulation in BALB/c mice with blood clearance half-life periods found to be 12 min.
DOTA-NHS-ester hexafluorophosphate TFA purchased from MedChemExpress. Usage Cited in: Adv Nanobiomed Res. 2023 Sep 3.
PSP–NH2 was incubated with DOTA–NHS–ester for 1 h and conjugated with mPEG–NHS. Then, the particles were mixed with 64Cu (OAc)2 at 50 ℃ for 1 h to obtain the 64Cu-labelled PSP. More PSP–NH2 accumulated in the liver site while a lot more PSP@Ab@PEG accumulated in the spleen.
Purity & Documentation
References
[1]. Hoppmann S, et al. Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting. Bioconjugate chemistry. 2011 Mar 16;22(3):413-21. [Content Brief]
[3]. Li C, et al. Theranostic application of Cu/Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. European journal of nuclear medicine and molecular imaging. 2022 Dec;50(1):168-183. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- DOTA-NHS-ester hexafluorophosphate
- 1823122-52-6
- Biochemical Assay Reagents
- tumor targeting
- subcutaneous pancreatic cancer tumor models
- lectin microarrays
- human serum albumin
- SPECT imaging
- anti-Trop2 monoclonal antibody hIMB1636
- 177Lu radiolabeling
- SKOV3 cells
- DOTA-HSA-ZHER2:342
- gold biochip surfaces
- Inhibitor
- inhibitor
- inhibit